Cargando…

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells

Mutations in IDH1, IDH2, and TET2 are recurrently observed in myeloid neoplasms. IDH1 and IDH2 encode isocitrate dehydrogenase isoforms, which normally catalyze the conversion of isocitrate to α-ketoglutarate (α-KG). Oncogenic IDH1/2 mutations confer neomorphic activity, leading to the production of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortin, Jerome, Chiang, Ming-Feng, Meydan, Cem, Foox, Jonathan, Ramachandran, Parameswaran, Leca, Julie, Lemonnier, François, Li, Wanda Y., Gams, Miki S., Sakamoto, Takashi, Chu, Mandy, Tobin, Chantal, Laugesen, Eric, Robinson, Troy M., You-Ten, Annick, Butler, Daniel J., Berger, Thorsten, Minden, Mark D., Levine, Ross L., Guidos, Cynthia J., Melnick, Ari M., Mason, Christopher E., Mak, Tak W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942850/ https://www.ncbi.nlm.nih.gov/pubmed/36652477 http://dx.doi.org/10.1073/pnas.2208176120

Ejemplares similares

Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F
por: Tefferi, A, et al.
Publicado: (2012)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Soyer, Nur, et al.
Publicado: (2017)

Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions
por: Kawamata, Norihiko, et al.
Publicado: (2011)

Using Bioinformatic Approaches to Identify Pathways Targeted by Human Leukemogens
por: Thomas, Reuben, et al.
Publicado: (2012)

Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice
por: Usenko, Tatiana, et al.
Publicado: (2014)

Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
por: Guilhamon, Paul, et al.
Publicado: (2013)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma()()
por: Stasik, Sebastian, et al.
Publicado: (2020)

Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
por: Barbieri, Elisa, et al.
Publicado: (2016)

Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
por: Huang, Dan, et al.
Publicado: (2023)

Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity
por: Azran, Inbal, et al.
Publicado: (2004)

Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen
Publicado: (1987)

Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways
por: Gow, Chien-Hung, et al.
Publicado: (2014)

Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9
por: Huang, Yun, et al.
Publicado: (2020)

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
por: Van Damme, Michaël, et al.
Publicado: (2016)

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice
Publicado: (1980)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
por: Lu, J-W, et al.
Publicado: (2017)

IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC
por: Xu, Qiang, et al.
Publicado: (2016)

DIPG-13. NEW IMMUNOCOMPETENT GENETICALLY-ENGINEERED MOUSE MODELS OF PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMAS REVEAL MECHANISMS OF TUMOR INITIATION AND PROGRESSION
por: Tian, Ruxiao, et al.
Publicado: (2023)

Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19
por: Bell, Lucy CK, et al.
Publicado: (2020)

Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation
por: Pierce, Andrew, et al.
Publicado: (2012)

Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia
por: Chen, Chiqi, et al.
Publicado: (2021)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)

Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion
por: Zhang, Ming, et al.
Publicado: (2022)

Transcriptome analysis reveals effects of leukemogenic SHP2 mutations in biosynthesis of amino acids signaling
por: Zhao, Yuming, et al.
Publicado: (2023)

The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
por: Kugler, Eitan, et al.
Publicado: (2023)

Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors
por: Zorzan, Eleonora, et al.
Publicado: (2015)

Transcriptional response modules characterize IL-1β and IL-6 activity in COVID-19
por: Bell, Lucy C.K., et al.
Publicado: (2020)

mIDH-associated DNA hypermethylation in acute myeloid leukemia reflects differentiation blockage rather than inhibition of TET-mediated demethylation
por: Wiehle, Laura, et al.
Publicado: (2017)

Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment
por: Zheng, Xiaomin, et al.
Publicado: (2009)

Correction: Identification of Nuclear Protein Targets for Six Leukemogenic Tyrosine Kinases Governed by Post-Translational Regulation
por: Pierce, Andrew, et al.
Publicado: (2013)

Crucial role of the Rap G protein signal in Notch activation and leukemogenicity of T-cell acute lymphoblastic leukemia
por: Doi, Keiko, et al.
Publicado: (2015)

Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)—multiple rather than a single mechanism
por: Gole, Boris, et al.
Publicado: (2015)

Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity
por: Weng, Stephanie, et al.
Publicado: (2016)

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
por: Tefferi, A
Publicado: (2010)

Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells
por: Gerecke, Christian, et al.
Publicado: (2019)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5gaoi1nh3lq9emt935d0r648na